user Sign In

QYResearch Account

Manage your Account and Access Personalized Content.

Sign in

Create Account with us

Manage your Account and Access Personalized Content.

Sign Up
       
  
×

Global Fosfomycin Trometamol Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published Date: 2019-04-13   |   Pages: 133   |   Tables: 163   | Report Id: 1087597   | Hits: 23 |   Chemical & Material



Summary

Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.

Mainly for the treatment of urinary tract infections such as cystitis, urethritis.

In the last several years, global market of fosfomycin trometamol developed smoothly, with an average growth rate of 7.8%. In 2015, global revenue of fosfomycin trometamol is nearly 44 million usd; the actual production is about 354 MT.

the global average price of fosfomycin trometamol is in the decreasing trend, from 131 USD /kg in 2011 to 124 USD/kg in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.

the classification of fosfomycin trometamol includes fosfomycin tromethamine granules and fosfomycin tromethamine powder, and the proportion of fosfomycin tromethamine granules in 2015 is about 56%.fosfomycin trometamol is widely used in urinary tract infection.

china is the largest supplier of fosfomycin trometamol, with a production market share nearly 83% in 2015. europe is the second largest supplier of fosfomycin trometamol, enjoying production market share nearly 15% in 2015.

north america is the largest consumption place, with a consumption market share nearly 36% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 31%. China is the world's largest exporting country.

market competition is not intense. Zambon and northesat pharm, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Fosfomycin Trometamol market was 48 million US$ in 2018 and is expected to 62 million US$ by the end of 2025, growing at a CAGR of 3.3% between 2019 and 2025.

This report studies the Fosfomycin Trometamol market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Fosfomycin Trometamol in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Zambon

Northesat Pharm

Hunan Huana Pharmaceuticals

Xunda Pharma

FarmaSino Pharmaceutical

Guilin Hwasun

By the product type, the market is primarily split into

Fosfomycin Tromethamine Granules

Fosfomycin Tromethamine Powder

By the end users/application, this report covers the following segments

Common Urinary Tract Infection

Postoperative Urinary Tract Infection

Preoperative Prevention of Urinary Tract Infection

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

The study objectives of this report are:

To study and analyze the global Fosfomycin Trometamol market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.

To understand the structure of Fosfomycin Trometamol market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Fosfomycin Trometamol manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Fosfomycin Trometamol with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Fosfomycin Trometamol submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Fosfomycin Trometamol are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million USD) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Fosfomycin Trometamol market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Fosfomycin Trometamol market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...